Welcome to our dedicated page for Phreesia SEC filings (Ticker: PHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Finding Phreesia’s patient-volume metrics or HIPAA compliance costs inside a 250-page filing can slow any analyst. Healthcare SaaS companies combine software revenue rules with healthcare regulations, making disclosures tough to parse. That’s why Stock Titan’s AI deciphers Phreesia SEC filings explained simply—turning dense accounting notes and regulatory risk sections into plain-language highlights.
Need to spot how subscription renewals trend across medical groups in the latest Phreesia quarterly earnings report 10-Q filing? Curious whether executives trimmed holdings before a product launch? Our platform links each disclosure to what matters for this business: 10-Ks outline retention rates and payment-processing margins, 8-K material events explained show new EHR partnerships, and every proxy statement executive compensation details incentive plans aligned with patient engagement growth. Meanwhile, real-time alerts surface Phreesia insider trading Form 4 transactions the moment they hit EDGAR, so you can monitor executive stock transactions Form 4 without refreshing the site.
Here’s how professionals use these insights: compare segment revenue across consecutive reports, track Form 4 insider transactions real-time to gauge leadership sentiment, and export AI summaries to brief stakeholders faster than manual review. Whether you’re understanding Phreesia SEC documents with AI for diligence, or need a Phreesia annual report 10-K simplified for board decks, Stock Titan keeps you current—complete coverage, automatic updates, and AI-driven earnings report filing analysis in one place.
Phreesia (PHR) reported an insider transaction by its President, Network Solutions. On 10/17/2025, the reporting person sold 2,059 shares of common stock (code S) at a weighted average price of $22.3612. The filing states the sales were non‑discretionary under the company’s mandatory sell‑to‑cover policy to satisfy tax withholding tied to the settlement of restricted stock units.
Following the transaction, the insider beneficially owned 171,829 shares directly and 9,883 shares indirectly through a spouse.
Phreesia (PHR): Officer Evan Roberts reported a Form 4 transaction showing the sale of 1,888 shares of common stock on 10/17/2025 at a weighted average price of $22.3612. The filing states the shares were disposed of in non-discretionary transactions under the issuer’s mandatory sell-to-cover policy to satisfy tax withholding tied to the settlement of performance-based RSUs.
Following the transaction, Roberts beneficially owned 724,949 shares, held directly.
Phreesia, Inc. (PHR) reported a Form 4 showing an officer transaction tied to tax withholding. On 10/17/2025, the company’s SVP, Human Resources disposed of 639 shares of common stock in non-discretionary sales under the issuer’s mandatory sell-to-cover policy related to the settlement of restricted stock units. The weighted average price was $22.3612, with individual trades executed between $22.195 and $22.66 per share.
Following the transactions, the reporting person beneficially owned 111,840 shares, held directly. The filing notes the availability of detailed trade breakdowns upon request.
Phreesia (PHR): A selling securityholder filed a Form 144 to sell 885 shares of common stock, with an approximate sale date of 10/17/2025 on the NYSE and an aggregate market value of 19789.66.
The 885 shares were acquired via restricted stock vesting on 10/14/2025 as compensation from the issuer. Shares outstanding were 59914473.
Recent Form 144 activity by Balaji Gandhi shows sales of 886 shares on 07/17/2025 for 23820.82, 9583 shares on 08/25/2025 for 287550.07, and 4183 shares on 09/16/2025 for 97398.65.
Phreesia (PHR) received a Rule 144 notice from Chaim Indig covering a proposed sale of 3,163 common shares with an aggregate market value of $70,728.48, with an approximate sale date of 10/17/2025 on the NYSE through Fidelity Brokerage Services LLC.
The shares to be sold were acquired via restricted stock vesting on 10/14/2025 as compensation. Recent Form 144 disclosures list prior sales by the filer in the last three months, including 92,247 shares on 08/27/2025, 7,746 on 08/28/2025, 6,328 on 09/16/2025, and 3,171 on 07/17/2025. Shares outstanding were 59,914,473.
Phreesia (PHR): A security holder filed a Form 144 notice to sell 1,241 common shares, with an aggregate market value of $27,750.25, on or about October 17, 2025 on the NYSE through Fidelity Brokerage Services.
The shares were acquired on October 14, 2025 via restricted stock vesting from the issuer as compensation. Phreesia reported 59,914,473 shares outstanding. The same seller disclosed prior 3‑month sales: 1,245 shares for $33,472.82 (07/17/2025), 3,133 shares for $72,950.03 (09/16/2025), and 2,059 shares for $48,386.50 (09/17/2025).
PHR filed a Form 144 notice for a planned sale of 2,059 common shares, with an aggregate market value of $46,041.71. The filer lists Fidelity Brokerage Services LLC as broker, an approximate sale date of 10/17/2025, and the NYSE as the exchange. The shares were acquired on 10/14/2025 via restricted stock vesting from the issuer as compensation.
Shares outstanding were 59,914,473 at the time referenced in the form. The filing also lists recent sales over the past three months by the named sellers, including multiple transactions with stated share counts and gross proceeds. This notice reflects intended sales under Rule 144 and pertains to the selling securityholder’s shares; it does not involve the company raising capital.
Phreesia (PHR) Form 4: Principal Accounting Officer Yvonne Hui reported a small insider transaction. On 10/15/2025, she sold 302 shares of Phreesia common stock in non-discretionary sell-to-cover trades to satisfy tax withholding related to restricted stock unit settlement. The weighted average sale price was $23.048 per share, with individual trades ranging from $22.84 to $23.265. After these transactions, her beneficial ownership stands at 30,336 shares, held directly.
PHR filed a Form 144 disclosing a proposed sale of 639 shares of common stock with an aggregate market value of $14,288.81, expected around 10/17/2025. The shares were acquired on 10/14/2025 via restricted stock vesting as compensation. The planned transaction lists Fidelity Brokerage Services LLC as broker and names the NYSE as the exchange.
The notice also lists recent sales by the same seller, including 640 shares on 07/17/2025 for $17,206.91, 18,573 shares on 08/25/2025 for $564,055.11, and 1,762 shares on 09/16/2025 for $41,027.11.
Phreesia (PHR): Form 144 filed for a planned sale of common stock. Evan Roberts filed a notice to sell 1,888 shares of Phreesia common stock through Fidelity Brokerage Services on the NYSE, with an approximate sale date of 10/17/2025 and an aggregate market value of $42,217.95.
The shares were acquired on 10/14/2025 via restricted stock vesting from the issuer as compensation. In the past three months, the filer reported sales of 1,892 shares on 07/17/2025 for $50,867.93, 45,147 shares on 08/27/2025 for $1,445,601.82, 3,400 shares on 08/28/2025 for $110,369.37, and 3,761 shares on 09/16/2025 for $87,572.63.
FAQ
What is the current stock price of Phreesia (PHR)?
What is the market cap of Phreesia (PHR)?
